Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Escherichia Coli Infections Clinical Presentation

  • Author: Tarun Madappa, MD, MPH; Chief Editor: Michael Stuart Bronze, MD  more...
 
Updated: Jan 11, 2016
 

History

Acute bacterial meningitis

Newborns with E coli meningitis present with fever and failure to thrive or abnormal neurologic signs. Other findings in neonates include jaundice, decreased feeding, periods of apnea, and listlessness.

Patients younger than 1 month present with irritability, lethargy, vomiting, lack of appetite, and seizures.

Those older than 4 months have neck rigidity, tense fontanels, and fever.

Older children and adults with acute E coli meningitis develop headache, vomiting, confusion, lethargy, seizures, and fever.

In rare cases, persons with a history of open CNS trauma or multiple neurological procedures develop S stercoralis hyperinfection.

Because patients who have undergone neurosurgery frequently have headaches, nuchal rigidity, and a decreased level of consciousness secondary to the surgery, signs may be difficult to interpret.

The differential diagnoses of acute E coli meningitis include sepsis, seizure disorder, brain abscess, ruptured aneurysm, and neonatal tetanus.

Pneumonia

Patients with E coli pneumonia usually present with fever, shortness of breath, increased respiratory rate, increased respiratory secretions, and crackles upon auscultation.

Findings include bronchopneumonia on chest radiography, commonly in the lower lobes. Many patients are intubated and have fever, an increased respiratory rate, and increased respiratory secretions.

The differential diagnoses of E coli pneumonia include congestive heart failure and pulmonary embolism. Other pneumonias caused by gram-negative bacilli are difficult to distinguish clinically.

Intra-abdominal infections

Patients with E coli cholecystitis or cholangitis develop right upper quadrant (RUQ) pain, fever, and jaundice. In severe cases, hypotension and confusion also develop. Cholecystitis manifests with fever (>102°F). Cholangitis manifests with fever (>102°F), shaking chills, and RUQ pain and can be complicated by hepatic abscess. Amebic liver abscess, Echinococcus cyst, and Klebsiella and Enterococcus infections are difficult to distinguish clinically. Anaerobes are observed in patients with diabetes and acute acalculous cholecystitis.

Patients with E coli intra-abdominal abscesses may have low-grade fever, but the spectrum of clinical presentations ranges from nonspecific abdominal examination findings to frank septic shock. Peritonitis manifests as localized pain with rebound and fever. The presentation ranges from low-grade fever with abdominal tenderness, weakness, malaise, and anorexia to hypoxemia and hypotension. The infection is usually polymicrobial with E coli and other gram-negative bacilli and anaerobes. The differential diagnoses include retroperitoneal hematoma and septic thrombophlebitis.

Enteric infections

Patients with E coli traveler's diarrhea (ie, watery nonbloody diarrhea; caused by enterotoxigenic E coli [ETEC] or enteroaggregative E coli [EAggEC]) may appear to be dehydrated. Traveler's diarrhea is observed in young healthy travelers to tropical countries and is watery diarrhea without polymorphonuclear (PMN) leukocytes. The differential diagnoses of E coli traveler's diarrhea include rotavirus infection, Norwalk virus infection, Salmonella infection, and Campylobacter diarrhea.

Patients with E coli childhood diarrhea (ie, watery nonbloody diarrhea; caused by EAggEC, enteroadherent E coli [EAEC], or enteropathogenic E coli [EPEC]) may also appear to be dehydrated. These infections produce a noninflammatory watery diarrhea observed especially in children. The differential diagnoses of E coli childhood diarrhea include Vibrio cholerae infection and Rotavirus infection.

In May, June, and July, 2011 an outbreak of gastroenteritis caused by Shiga-toxin–producing E coli was seen in Germany. The majority of patients were adults and 22% of the cases developed hemolytic–uremic syndrome The outbreak strain was typed as an enteroaggregative Shiga-toxin–producing E coli O104:H4, producing extended-spectrum beta-lactamase. The consumption of sprouts was identified as the most likely vehicle of infection. This outbreak was different as it was caused by EAggEC that produced a Shiga toxin and it exemplifies the threat posed by foodborne pathogens with their propensity to cause large common-source outbreaks.[2, 3]

Patients with E coli dysentery (caused by enteroinvasive E coli [EIEC] or enterohemorrhagic E coli [EHEC]) have fever, bloody diarrhea, and dehydration. Intestinal mucosa produces a significant inflammatory response. Clinically, patients with E coli dysentery present with fever and have blood and PMN leukocytes in their stool. The differential diagnoses of E coli dysentery include shigellosis and amebic dysentery.

Patients with E coli HUS (caused by EHEC) have fever, bloody diarrhea, dehydration, hemolysis, thrombocytopenia, and uremia requiring dialysis. Symptoms of E coli HUS range from asymptomatic to nonbloody diarrhea to bloody diarrhea, renal failure, microangiopathic hemolytic anemia, thrombocytopenia, and CNS manifestations. The differential diagnoses of E coli HUS include Shigella infections, Clostridium difficile enterocolitis, ulcerative colitis/Crohn disease, ischemic colitis, diverticulosis, and appendicitis.

Urinary tract infections

Acute E coliurethral syndrome manifests as low-grade fever and dysuria. Patients present with dysuria, increased frequency, and urgency, and they have colony counts. S saprophyticus infection is observed in 5-10% of cases, especially in sexually active women, associated with alkaline pH and microscopic hematuria. Less commonly, patients have Proteus mirabilis, Klebsiella, or Enterococcus infections. Approximately 15% of cases are culture-negative; these are due to Chlamydia trachomatis, Ureaplasma urealyticum, or Mycoplasma hominis infection.

Patients with symptomatic E coli UTI have dysuria and may have low-grade fever.

Patients with E coli pyelonephritis or complicated UTI present with localized flank or low back pain, high fever (>102°F), and urinary frequency and urgency. Findings also include rigors, sweating, headache, nausea, and vomiting. It can be complicated by necrotizing intrarenal or perinephric abscess, which manifests as a bulging flank mass or pyelonephritis that does not respond to antibiotics. Patients with diabetes or urinary tract obstruction can also develop bacteremia and septicemia. The differential diagnoses include psoas abscess appendicitis, ectopic pregnancy, and ruptured ovarian cyst.

Patients with E coliacute prostatitis or prostatic abscess have chills, sudden fever (>102°F), and perineal and back pain with a tender, swollen, indurated, and hot prostate. Acute prostatitis also manifests as dysuria, urgency, and frequent voiding. Some patients may have myalgia, urinary retention, malaise, and arthralgia. If the patient does not respond to antibiotics, consider prostatic abscess and confirm it with imaging studies. Treatment consists of open surgical or percutaneous drainage.

Patients with E coli prostatic abscess, which manifests as a complication of acute prostatitis, have a high fever despite adequate antimicrobial therapy and fluctuance of the prostate upon rectal examination.

The differential diagnoses of E coli acute prostatitis or prostatic abscess can include chronic bacterial prostatitis, which is usually asymptomatic; some patients may have frequency, dysuria, and nocturia with pain and discomfort in the perineal, suprapubic, penile, scrotal, or groin region. Also included are infected prostatic calculi, which can cause recurrent UTIs and should be surgically removed. Finally, nonbacterial prostatitis is also a differential diagnostic possibility and manifests as perineal, suprapubic scrotal, low back, or urethral tip pain.

Additionally, patients with E coli renal abscess present with fever, pleuritic chest pain secondary to diaphragmatic irritation, and flank pain, with or without a palpable abdominal mass.[2]

Next

Physical

Acute bacterial meningitis

E coli is a common cause of meningitis in newborns and is associated most frequently with prematurity.

E coli meningitis can be acquired during birth or can develop secondarily after infection in another body site, such as in cases of omphalitis, upper respiratory tract infection, or infected circumcision wound.

In adults, E coli meningitis is not uncommon in those who have undergone multiple neurological procedures or who have had open CNS trauma.

Immunosuppressed patients receiving corticosteroid therapy and those with S stercoralis hyperinfection are also at risk for E coli meningitis.

Pneumonia

E coli pneumonia is often preceded by colonization of the upper respiratory tract (eg, nasopharynx).

Community-acquired E coli pneumonia has been reported in rare cases.

Intra-abdominal infections

Along with Enterococcus faecalis and Klebsiella species, E coli is one of the most common organisms associated with cholecystitis/cholangitis and intra-abdominal abscesses, as part of polymicrobial flora including anaerobes.

E coli cholecystitis/cholangitis manifests as the classic Charcot triad of fever, pain, and jaundice in 70% of cases. Fever is the most common finding (95%). RUQ pain and jaundice may be absent if no obstruction is present.

In late stages, hypotension, confusion, and renal failure are observed.

Liver abscess can develop as a complication of a E coli biliary tract infection.

The findings of E coli intra-abdominal abscesses are less conspicuous than those of diffuse peritonitis. The patient may have only low-grade fever, generalized malaise, and anorexia. In the postoperative patient who may have a distended and tender abdomen, clinical diagnosis of E coli intra-abdominal abscess may be difficult.

Enteric infections

Traveler's diarrhea usually occurs in persons from industrialized countries who visit tropical or subtropical regions and develop abdominal cramps and frequent explosive bowel movements 1-2 days after exposure to contaminated food or water.

E coli enterotoxin acts on the GI mucosa, leading to an outpouring of copious fluid from the small bowel.

The symptoms usually last 3-4 days and are self-limited.

Large fluid loss may result in dehydration.

EIEC infections are rare and manifest as bloody diarrheal stool containing PMN leukocytes. Patients usually have fever, abdominal cramping, and tenesmus lasting 5-7 days.

Childhood diarrhea is due to EPEC strains and usually occurs in underdeveloped countries or nursery outbreaks. The volume of diarrhea is less than that with ETEC strains, and no inflammatory cells are found in the diarrheal fluid. The child may experience fever, and diarrhea lasts longer than 2 weeks in some cases.

Infection with EHEC strains of the serotype 0157:H7 begin as watery diarrhea followed by grossly bloody stool without inflammatory PMN cells and results in HUS in 10% of cases, characterized by hemolysis, thrombocytopenia, uremia (possibly requiring dialysis), and death in some cases.

EAggEC and EAEC cause clinical illnesses that are not yet well characterized and are associated with persistent diarrhea in children.

Urinary tract infections

E coli is the leading cause of community-acquired and nosocomial UTI.

Females are predisposed to UTI because of their anatomy and changes during sexual maturation, pregnancy, and childbirth.

Young boys with posterior urethral valves are also predisposed to UTIs, as are elderly men with prostatic hypertrophy.

Other risk factors include catheterization or mechanical manipulation, obstruction, or diabetes.

Patients with E coli UTI present with a wide spectrum of symptoms, ranging from asymptomatic cystitis to pyelonephritis/perinephric abscess.

Urethral syndrome is a term used to describe symptoms of dysuria with colony counts less than 100,000 colony-forming units/mL of urine.

Uncomplicated E coli acute cystitis may manifest as low-grade fever, dysuria, and increased urinary frequency.

Acute pyelonephritis manifests as high-grade fever (>102°F) and costovertebral tenderness.

Acute prostatitis manifests as a sudden onset of fever and chills with perineal and low back pain.

Perinephric abscess may manifest as a bulging flank mass. GI symptoms such as nausea and vomiting are more likely in elderly persons. Patients with bacteremia secondary to an obstructed urinary catheter may present with decreased urine output.

Prostatic abscess can occur as a complication of acute prostatitis, notably in patients with diabetes mellitus, and should be considered in patients with acute prostatitis or UTI that is not improving with adequate antimicrobial therapy.

Other infections

E coli bacteremia can lead to septic shock, manifesting as hypotension and fever (in some cases, with hypothermia rather than fever). It may be complicated by uremia, hepatic failure, acute respiratory distress syndrome, stupor or coma, and death. Non–life-threatening E coli bacteremia may manifest as a sudden onset of fever and chills, tachycardia, tachypnea, and mental confusion. In cases of E coli UTI with urinary tract obstruction, bacteremia or septicemia may ensue.

A retrospective study determined risk factors for mortality in patients with fluoroquinolone-resistant E coli. Results show fluoroquinolone resistance, cirrhosis, and cardiac dysfunction independently predicted mortality.[4]

Several cases of E coliendophthalmitis have been reported in patients with diabetes who have UTI or pyelonephritis.[5]

Previous
Next

Causes

Table. Differential Diagnoses of E coli Infection (Open Table in a new window)

Organism Ind* Urease Motility Glu Ferm† Lact Ferm‡ Sucr Ferm§ Malt Ferm|| Esc Hyd¶ Hyd Sulf TSI# Oxidase Orn Dec** Lys Dec††
E coli + - + + + +/- + - - - +/- +
Klebsiella pneumoniae - +/- - + + + + + - - - +
P mirabilis - + + + - - - - + - + -
Proteus vulgaris + + + + - + + +/- + - - -
Pseudomonas aeruginosa - +/- + +



(ox)‡‡



- - - - - + - -
Enterobacter aerogenes - - + + + + + + - - + +
Enterobacter cloacae - - + + + + + - - - + -
Salmonella typhi - - + + - - + - + - - +
Citrobacter freundii +/- - + + + + + - +/- - - -
Serratia marcescens - +/- + + - + + + - - + +
*Indole



†Glucose fermentation



‡Lactose fermentation



§Sucrose fermentation



||Maltose fermentation



¶Esculin hydrolysis



#Hydrogen sulfite on TSI



**Ornithine decarboxylase



††Lysine decarboxylase



‡‡Oxidative



Previous
 
 
Contributor Information and Disclosures
Author

Tarun Madappa, MD, MPH Attending Physician, Department of Pulmonary and Critical Care Medicine, Christus Spohn-Shoreline Hospital

Tarun Madappa, MD, MPH is a member of the following medical societies: American College of Chest Physicians, American Thoracic Society

Disclosure: Nothing to disclose.

Coauthor(s)

Chi Hiong U Go, MD Assistant Professor, Department of Internal Medicine, Texas Tech University Health Science Center at Odessa

Chi Hiong U Go, MD is a member of the following medical societies: American College of Physicians-American Society of Internal Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Charles V Sanders, MD Edgar Hull Professor and Chairman, Department of Internal Medicine, Professor of Microbiology, Immunology and Parasitology, Louisiana State University School of Medicine at New Orleans; Medical Director, Medicine Hospital Center, Charity Hospital and Medical Center of Louisiana at New Orleans; Consulting Staff, Ochsner Medical Center

Charles V Sanders, MD is a member of the following medical societies: American College of Physicians, Alliance for the Prudent Use of Antibiotics, The Foundation for AIDS Research, Southern Society for Clinical Investigation, Southwestern Association of Clinical Microbiology, Association of Professors of Medicine, Association for Professionals in Infection Control and Epidemiology, American Clinical and Climatological Association, Infectious Disease Society for Obstetrics and Gynecology, Orleans Parish Medical Society, Southeastern Clinical Club, American Association for the Advancement of Science, Alpha Omega Alpha, American Association of University Professors, American Association for Physician Leadership, American Federation for Medical Research, American Geriatrics Society, American Lung Association, American Medical Association, American Society for Microbiology, American Thoracic Society, American Venereal Disease Association, Association of American Medical Colleges, Association of American Physicians, Infectious Diseases Society of America, Louisiana State Medical Society, Royal Society of Medicine, Sigma Xi, Society of General Internal Medicine, Southern Medical Association

Disclosure: Received royalty from Baxter International for other.

Chief Editor

Michael Stuart Bronze, MD David Ross Boyd Professor and Chairman, Department of Medicine, Stewart G Wolf Endowed Chair in Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center; Master of the American College of Physicians; Fellow, Infectious Diseases Society of America

Michael Stuart Bronze, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, Oklahoma State Medical Association, Southern Society for Clinical Investigation, Association of Professors of Medicine, American College of Physicians, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Additional Contributors

Larry I Lutwick, MD Professor of Medicine, State University of New York Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus

Larry I Lutwick, MD is a member of the following medical societies: American College of Physicians, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Eleftherios Mylonakis, MD, to the development and writing of this article.

References
  1. Kappeli U, Hachler H, Giezendanner N, Beutin L, Stephan R. Human Infections with Non-O157 Shiga Toxin-producing Escherichia coli, Switzerland, 2000-2009. Emerg Infect Dis. 2011 Feb. 17(2):180-5. [Medline].

  2. Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med. 2011 Nov 10. 365(19):1771-80. [Medline].

  3. Buchholz U, Bernard H, Werber D, Böhmer MM, Remschmidt C, Wilking H, et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med. 2011 Nov 10. 365(19):1763-70. [Medline].

  4. Camins BC, Marschall J, De Vader SR, Maker DE, Hoffman MW, Fraser VJ. The clinical impact of fluoroquinolone resistance in patients with E coli bacteremia. J Hosp Med. 2011 Jul. 6(6):344-9. [Medline]. [Full Text].

  5. Walmsley RS, David DB, Allan RN, Kirkby GR. Bilateral endogenous Escherichia coli endophthalmitis: a devastating complication in an insulin-dependent diabetic. Postgrad Med J. 1996 Jun. 72(848):361-3. [Medline].

  6. McGannon CM, Fuller CA, Weiss AA. Different classes of antibiotics differentially influence shiga toxin production. Antimicrob Agents Chemother. 2010 Sep. 54(9):3790-8. [Medline].

  7. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008 Mar. 8(3):159-66. [Medline].

  8. Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect. 2007 Sep. 55(3):254-9. [Medline].

  9. Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, et al. Community-associated extended-spectrum ß-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013 Mar. 56(5):641-8. [Medline]. [Full Text].

  10. Batard E, Ollivier F, Boutoille D, Hardouin JB, Montassier E, Caillon J, et al. Relationship between hospital antibiotic use and quinolone resistance in Escherichia coli. Int J Infect Dis. 2012 Nov 22. [Medline].

  11. Karlowsky JA, Denisuik AJ, Lagacé-Wiens PR, Adam HJ, Baxter MR, Hoban DJ, et al. In Vitro Activity of Fosfomycin against Escherichia coli Isolated from Patients with Urinary Tract Infections in Canada; CANWARD Surveillance Study. Antimicrob Agents Chemother. 2013 Dec 9. [Medline].

  12. Agustin ET, Gill V, Domenico P. CSF gram stain in meningitis. Intern Med. 1994. 15:14-24.

  13. Barnett BJ, Stephens DS. Urinary tract infection: an overview. Am J Med Sci. 1997 Oct. 314(4):245-9. [Medline].

  14. Boam WD, Miser WF. Acute focal bacterial pyelonephritis. Am Fam Physician. 1995 Sep 1. 52(3):919-24. [Medline].

  15. Bohnen JM. Antibiotic therapy for abdominal infection. World J Surg. 1998 Feb. 22(2):152-7. [Medline].

  16. Bonoan JT, Mehra S, Cunha BA. Emphysematous pyelonephritis. Heart Lung. 1997 Nov-Dec. 26(6):501-3. [Medline].

  17. Carpenter HA. Bacterial and parasitic cholangitis. Mayo Clin Proc. 1998 May. 73(5):473-8. [Medline].

  18. Childs SJ. Current concepts in the treatment of urinary tract infections and prostatitis. Am J Med. 1991 Dec 30. 91(6A):120S-123S. [Medline].

  19. Cunha BA. Abdominal pain in patients with diabetis mellitus. Infect Dis Prac. 1997. 21:14-5.

  20. Cunha BA. Acute acalculous cholecystitis. Infect Dis Prac. 1997. 21:70-1.

  21. Cunha BA. Acute and chronic bacterial prostatitis. Infect Dis Prac. 1994. 18:78-9.

  22. Cunha BA. Antibiotic concentration dependent susceptibility of urinary tract isolates. Antib Clinician. 1999. 3:57-8.

  23. Cunha BA. Quinolones: Clinical aspects. Antib Clinician. 1998. 2:129-35.

  24. Cunha BA. The fluoroquinolones for urinary tract infections: a review. Adv Ther. 1994 Nov-Dec. 11(6):277-96. [Medline].

  25. Cunha BA. Therapeutic approach in treating UTIs. Antib Clinician. 1998. 2(S2):35-40.

  26. Cunha BA. Urine gram stain in urosepsis. Intern Med. 1997. 18:75-8.

  27. Cunha BA. Urosepsis. J Crit Ill. 1997. 12:616-25.

  28. Donnenberg MS, Kaper JB. Enteropathogenic Escherichia coli. Infect Immun. 1992 Oct. 60(10):3953-61. [Medline].

  29. DuPont HL. Travellers' diarrhoea: contemporary approaches to therapy and prevention. Drugs. 2006. 66(3):303-14. [Medline].

  30. Eisenstein BI, Jones GW. The spectrum of infections and pathogenic mechanisms of Escherichia coli. Adv Intern Med. 1988. 33:231-52. [Medline].

  31. Glandt M, Adachi JA, Mathewson JJ, Jiang ZD, DiCesare D, Ashley D. Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin. Clin Infect Dis. 1999 Aug. 29(2):335-8. [Medline].

  32. Gold R. Bacterial meningitis--1982. Am J Med. 1983 Jul 28. 75(1B):98-101. [Medline].

  33. Hansing CE, Allen VD, Cherry JD. Escherichia coli endocarditis. A review of the literature and a case study. Arch Intern Med. 1967 Oct. 120(4):472-7. [Medline].

  34. Harrington SM, Dudley EG, Nataro JP. Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett. 2006 Jan. 254(1):12-8. [Medline].

  35. Harvey D, Holt DE, Bedford H. Bacterial meningitis in the newborn: a prospective study of mortality and morbidity. Semin Perinatol. 1999 Jun. 23(3):218-25. [Medline].

  36. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev. 1991 Jan. 4(1):80-128. [Medline].

  37. Jonas M, Cunha BA. Bacteremic Escherichia coli pneumonia. Arch Intern Med. 1982 Nov. 142(12):2157-9. [Medline].

  38. Klein NC, Cunha BA. Third-generation cephalosporins. Med Clin North Am. 1995 Jul. 79(4):705-19. [Medline].

  39. Koutkia P, Mylonakis E, Flanigan T. Enterohemorrhagic Escherichia coli O157:H7--an emerging pathogen. Am Fam Physician. 1997 Sep 1. 56(3):853-6, 859-61. [Medline].

  40. Lepelletier D, Caroff N, Reynaud A, Richet H. Escherichia coli: epidemiology and analysis of risk factors for infections caused by resistant strains. Clin Infect Dis. 1999 Sep. 29(3):548-52. [Medline].

  41. Lerner AM. The gram-negative bacillary pneumonias. Dis Mon. 1980 Nov. 27(2):1-56. [Medline].

  42. McDonald MI. Pyogenic liver abscess: diagnosis, bacteriology and treatment. Eur J Clin Microbiol. 1984 Dec. 3(6):506-9. [Medline].

  43. Mead PS, Griffin PM. Escherichia coli O157:H7. Lancet. 1998 Oct 10. 352(9135):1207-12. [Medline].

  44. Moon HW. Pathogenesis of enteric diseases caused by Escherichia coli. Adv Vet Sci Comp Med. 1974. 18(0):179-211. [Medline].

  45. Neu HC. Infections due to gram-negative bacteria: an overview. Rev Infect Dis. 1985 Nov-Dec. 7 Suppl 4:S778-82. [Medline].

  46. Nordmann P. Trends in beta-lactam resistance among Enterobacteriaceae. Clin Infect Dis. 1998 Aug. 27 Suppl 1:S100-6. [Medline].

  47. Ortega AM, Cunha BA. Acute prostatitis. Contemp Urol. 1997. 18:73-80.

  48. Palmer DL. Microbiology of pneumonia in the patient at risk. Am J Med. 1984 May 15. 76(5A):53-60. [Medline].

  49. Phillips AD, Frankel G. Mechanisms of gut damage by Escherichia coli. Baillieres Clin Gastroenterol. 1997 Sep. 11(3):465-83. [Medline].

  50. Roberts JA. Pyelonephritis, cortical abscess, and perinephric abscess. Urol Clin North Am. 1986 Nov. 13(4):637-45. [Medline].

  51. Savatta D, Cunha BA. Acute pyelonephritis and its mimics: Xanthogranulomaotus pyelonephritis and malacoplakia. Infect Dis Prac. 1996. 20:86-8.

  52. Schimpff SC. Gram-negative bacteremia. Support Care Cancer. 1993 Jan. 1(1):5-18. [Medline].

  53. Schindzielorz A, Edberg SC, Bia FJ. Strongyloides stercoralis hyperinfection and central nervous system involvement in a patient with relapsing polychondritis. South Med J. 1991 Aug. 84(8):1055-7. [Medline].

  54. Shea KW, Cunha BA. Escherichia coli sternal osteomyelitis after open heart surgery. Heart Lung. 1995 Mar-Apr. 24(2):177-8. [Medline].

  55. Tabacof J, Feher O, Katz A, et al. Strongyloides hyperinfection in two patients with lymphoma, purulent meningitis, and sepsis. Cancer. 1991 Oct 15. 68(8):1821-3. [Medline].

  56. Tan JS, File TM. Urinary tract infections in obstetrics and gynecology. J Reprod Med. 1990 Mar. 35(3 Suppl):339-42. [Medline].

  57. Tenner SM, Yadven MW, Kimmel PL. Acute pyelonephritis. Preventing complications through prompt diagnosis and proper therapy. Postgrad Med. 1992 Feb 1. 91(2):261-8. [Medline].

  58. Tice AD. Short-course therapy of acute cystitis: a brief review of therapeutic strategies. J Antimicrob Chemother. 1999 Mar. 43 Suppl A:85-93. [Medline].

  59. Wanke CA. Escherichia coli. J Diarrhoeal Dis Res. 1988 Mar. 6(1):1-5. [Medline].

  60. Weinberger M, Cytron S, Servadio C, et al. Prostatic abscess in the antibiotic era. Rev Infect Dis. 1988 Mar-Apr. 10(2):239-49. [Medline].

  61. Westphal JF, Brogard JM. Biliary tract infections: a guide to drug treatment. Drugs. 1999 Jan. 57(1):81-91. [Medline].

  62. Whipp SC, Rasmussen MA, Cray WC Jr. Animals as a source of Escherichia coli pathogenic for human beings. J Am Vet Med Assoc. 1994 Apr 15. 204(8):1168-75. [Medline].

 
Previous
Next
 
Escherichia coli liver abscess.
Escherichia coli right pyelonephritis.
Escherichia coli on Gram stain. Gram-negative bacilli.
Escherichia coli culture on MacConkey agar.
Table. Differential Diagnoses of E coli Infection
Organism Ind* Urease Motility Glu Ferm† Lact Ferm‡ Sucr Ferm§ Malt Ferm|| Esc Hyd¶ Hyd Sulf TSI# Oxidase Orn Dec** Lys Dec††
E coli + - + + + +/- + - - - +/- +
Klebsiella pneumoniae - +/- - + + + + + - - - +
P mirabilis - + + + - - - - + - + -
Proteus vulgaris + + + + - + + +/- + - - -
Pseudomonas aeruginosa - +/- + +



(ox)‡‡



- - - - - + - -
Enterobacter aerogenes - - + + + + + + - - + +
Enterobacter cloacae - - + + + + + - - - + -
Salmonella typhi - - + + - - + - + - - +
Citrobacter freundii +/- - + + + + + - +/- - - -
Serratia marcescens - +/- + + - + + + - - + +
*Indole



†Glucose fermentation



‡Lactose fermentation



§Sucrose fermentation



||Maltose fermentation



¶Esculin hydrolysis



#Hydrogen sulfite on TSI



**Ornithine decarboxylase



††Lysine decarboxylase



‡‡Oxidative



Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.